HEADER APOPTOSIS/INHIBITOR 09-AUG-16 5LOF TITLE CRYSTAL STRUCTURE OF THE MBP-MCL1 COMPLEX WITH HIGHLY SELECTIVE AND TITLE 2 POTENT INHIBITOR OF MCL1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTOSE-BINDING PERIPLASMIC PROTEIN,INDUCED MYELOID COMPND 3 LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: MBP,MMBP,MALTODEXTRIN-BINDING PROTEIN,BCL-2-LIKE PROTEIN 3, COMPND 6 BCL2-L-3,BCL-2-RELATED PROTEIN EAT/MCL1,MCL1/EAT; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI O157:H7, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 83334, 9606; SOURCE 5 GENE: MALE, Z5632, ECS5017, MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: PLYSS KEYWDS APOPTOSIS-INHIBITOR COMPLEX, MCL-1, S S63845, MBP EXPDTA X-RAY DIFFRACTION AUTHOR P.DOKURNO,A.KOTSCHY,Z.SZLAVIK,J.MURRAY,J.DAVIDSON,M.CSEKEI,A.PACZAL, AUTHOR 2 Z.SZABO,S.SIPOS,G.RADICS,A.PROSZENYAK,B.BALINT,L.ONDI,G.BLASKO, AUTHOR 3 A.ROBERTSON,A.SURGENOR,I.CHEN,N.MATASSOVA,J.SMITH,C.PEDDER,C.GRAHAM, AUTHOR 4 O.GENESTE REVDAT 5 10-JAN-24 5LOF 1 HETSYN REVDAT 4 29-JUL-20 5LOF 1 COMPND REMARK HET HETNAM REVDAT 4 2 1 FORMUL LINK SITE ATOM REVDAT 3 09-NOV-16 5LOF 1 JRNL REVDAT 2 02-NOV-16 5LOF 1 JRNL REVDAT 1 26-OCT-16 5LOF 0 JRNL AUTH A.KOTSCHY,Z.SZLAVIK,J.MURRAY,J.DAVIDSON,A.L.MARAGNO, JRNL AUTH 2 G.LE TOUMELIN-BRAIZAT,M.CHANRION,G.L.KELLY,J.N.GONG, JRNL AUTH 3 D.M.MOUJALLED,A.BRUNO,M.CSEKEI,A.PACZAL,Z.B.SZABO,S.SIPOS, JRNL AUTH 4 G.RADICS,A.PROSZENYAK,B.BALINT,L.ONDI,G.BLASKO,A.ROBERTSON, JRNL AUTH 5 A.SURGENOR,P.DOKURNO,I.CHEN,N.MATASSOVA,J.SMITH,C.PEDDER, JRNL AUTH 6 C.GRAHAM,A.STUDENY,G.LYSIAK-AUVITY,A.M.GIRARD,F.GRAVE, JRNL AUTH 7 D.SEGAL,C.D.RIFFKIN,G.POMILIO,L.C.GALBRAITH,B.J.AUBREY, JRNL AUTH 8 M.S.BRENNAN,M.J.HEROLD,C.CHANG,G.GUASCONI,N.CAUQUIL, JRNL AUTH 9 F.MELCHIORE,N.GUIGAL-STEPHAN,B.LOCKHART,F.COLLAND, JRNL AUTH10 J.A.HICKMAN,A.W.ROBERTS,D.C.HUANG,A.H.WEI,A.STRASSER, JRNL AUTH11 G.LESSENE,O.GENESTE JRNL TITL THE MCL1 INHIBITOR S63845 IS TOLERABLE AND EFFECTIVE IN JRNL TITL 2 DIVERSE CANCER MODELS. JRNL REF NATURE V. 538 477 2016 JRNL REFN ESSN 1476-4687 JRNL PMID 27760111 JRNL DOI 10.1038/NATURE19830 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0151 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 3 NUMBER OF REFLECTIONS : 25921 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.184 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1336 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.32 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3725 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.87 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 195 REMARK 3 BIN FREE R VALUE : 0.3270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3975 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 80 REMARK 3 SOLVENT ATOMS : 183 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 46.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.01000 REMARK 3 B22 (A**2) : -4.52000 REMARK 3 B33 (A**2) : 1.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.279 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.213 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.177 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.421 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.940 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4149 ; 0.015 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 3909 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5638 ; 1.647 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9008 ; 1.009 ; 2.987 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 512 ; 5.721 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 181 ;37.266 ;24.972 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 678 ;17.812 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 17 ;21.734 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 623 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4690 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 910 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2054 ; 3.508 ; 4.533 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2053 ; 3.508 ; 4.532 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2564 ; 4.866 ; 6.777 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 2565 ; 4.865 ; 6.779 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2095 ; 4.163 ; 4.956 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2094 ; 4.164 ; 4.957 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3075 ; 6.379 ; 7.233 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 19082 ; 8.820 ;85.954 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 19072 ; 8.821 ;85.945 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5LOF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1200001029. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97857 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 S 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28314 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.170 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4WGI REMARK 200 REMARK 200 REMARK: ROD-LIKE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.2M MAGNESIUM FORMATE, REMARK 280 1MM MALTOSE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 284K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 49.70000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 68.38000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 49.70000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 68.38000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -196 REMARK 465 ALA A -24 REMARK 465 ALA A -23 REMARK 465 GLY A -22 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A -26 CG CD CE NZ REMARK 470 TYR A -25 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A -21 CG CD CE NZ REMARK 470 LYS A -17 CG CD CE NZ REMARK 470 LYS A 238 CG CD CE NZ REMARK 470 LYS A 244 CG CD CE NZ REMARK 470 ARG A 248 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 252 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 120 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG A 176 NE - CZ - NH2 ANGL. DEV. = 3.8 DEGREES REMARK 500 ARG A 187 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 ARG A 263 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 VAL A 297 CB - CA - C ANGL. DEV. = -13.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A -28 -70.50 -84.54 REMARK 500 LYS A 6 11.15 84.40 REMARK 500 REMARK 500 REMARK: NULL DBREF 5LOF A -195 170 UNP P0AEY0 MALE_ECO57 27 392 DBREF 5LOF A 173 321 UNP Q07820 MCL1_HUMAN 173 321 SEQADV 5LOF MET A -196 UNP P0AEY0 INITIATING METHIONINE SEQADV 5LOF ALA A -24 UNP P0AEY0 GLU 198 ENGINEERED MUTATION SEQADV 5LOF ALA A -23 UNP P0AEY0 ASN 199 ENGINEERED MUTATION SEQADV 5LOF ALA A 43 UNP P0AEY0 LYS 265 ENGINEERED MUTATION SEQADV 5LOF GLY A 171 UNP P0AEY0 LINKER SEQADV 5LOF SER A 172 UNP P0AEY0 LINKER SEQADV 5LOF ALA A 194 UNP Q07820 LYS 194 ENGINEERED MUTATION SEQADV 5LOF ALA A 197 UNP Q07820 LYS 197 ENGINEERED MUTATION SEQADV 5LOF ALA A 201 UNP Q07820 ARG 201 ENGINEERED MUTATION SEQRES 1 A 518 MET LYS ILE GLU GLU GLY LYS LEU VAL ILE TRP ILE ASN SEQRES 2 A 518 GLY ASP LYS GLY TYR ASN GLY LEU ALA GLU VAL GLY LYS SEQRES 3 A 518 LYS PHE GLU LYS ASP THR GLY ILE LYS VAL THR VAL GLU SEQRES 4 A 518 HIS PRO ASP LYS LEU GLU GLU LYS PHE PRO GLN VAL ALA SEQRES 5 A 518 ALA THR GLY ASP GLY PRO ASP ILE ILE PHE TRP ALA HIS SEQRES 6 A 518 ASP ARG PHE GLY GLY TYR ALA GLN SER GLY LEU LEU ALA SEQRES 7 A 518 GLU ILE THR PRO ASP LYS ALA PHE GLN ASP LYS LEU TYR SEQRES 8 A 518 PRO PHE THR TRP ASP ALA VAL ARG TYR ASN GLY LYS LEU SEQRES 9 A 518 ILE ALA TYR PRO ILE ALA VAL GLU ALA LEU SER LEU ILE SEQRES 10 A 518 TYR ASN LYS ASP LEU LEU PRO ASN PRO PRO LYS THR TRP SEQRES 11 A 518 GLU GLU ILE PRO ALA LEU ASP LYS GLU LEU LYS ALA LYS SEQRES 12 A 518 GLY LYS SER ALA LEU MET PHE ASN LEU GLN GLU PRO TYR SEQRES 13 A 518 PHE THR TRP PRO LEU ILE ALA ALA ASP GLY GLY TYR ALA SEQRES 14 A 518 PHE LYS TYR ALA ALA GLY LYS TYR ASP ILE LYS ASP VAL SEQRES 15 A 518 GLY VAL ASP ASN ALA GLY ALA LYS ALA GLY LEU THR PHE SEQRES 16 A 518 LEU VAL ASP LEU ILE LYS ASN LYS HIS MET ASN ALA ASP SEQRES 17 A 518 THR ASP TYR SER ILE ALA GLU ALA ALA PHE ASN LYS GLY SEQRES 18 A 518 GLU THR ALA MET THR ILE ASN GLY PRO TRP ALA TRP SER SEQRES 19 A 518 ASN ILE ASP THR SER ALA VAL ASN TYR GLY VAL THR VAL SEQRES 20 A 518 LEU PRO THR PHE LYS GLY GLN PRO SER LYS PRO PHE VAL SEQRES 21 A 518 GLY VAL LEU SER ALA GLY ILE ASN ALA ALA SER PRO ASN SEQRES 22 A 518 LYS GLU LEU ALA LYS GLU PHE LEU GLU ASN TYR LEU LEU SEQRES 23 A 518 THR ASP GLU GLY LEU GLU ALA VAL ASN LYS ASP LYS PRO SEQRES 24 A 518 LEU GLY ALA VAL ALA LEU LYS SER TYR GLU GLU GLU LEU SEQRES 25 A 518 ALA LYS ASP PRO ARG ILE ALA ALA THR MET GLU ASN ALA SEQRES 26 A 518 GLN LYS GLY GLU ILE MET PRO ASN ILE PRO GLN MET SER SEQRES 27 A 518 ALA PHE TRP TYR ALA VAL ARG THR ALA VAL ILE ASN ALA SEQRES 28 A 518 ALA SER GLY ARG GLN THR VAL ASP GLU ALA LEU LYS ASP SEQRES 29 A 518 ALA GLN THR GLY SER GLU LEU TYR ARG GLN SER LEU GLU SEQRES 30 A 518 ILE ILE SER ARG TYR LEU ARG GLU GLN ALA THR GLY ALA SEQRES 31 A 518 ALA ASP THR ALA PRO MET GLY ALA SER GLY ALA THR SER SEQRES 32 A 518 ARG LYS ALA LEU GLU THR LEU ARG ARG VAL GLY ASP GLY SEQRES 33 A 518 VAL GLN ARG ASN HIS GLU THR ALA PHE GLN GLY MET LEU SEQRES 34 A 518 ARG LYS LEU ASP ILE LYS ASN GLU ASP ASP VAL LYS SER SEQRES 35 A 518 LEU SER ARG VAL MET ILE HIS VAL PHE SER ASP GLY VAL SEQRES 36 A 518 THR ASN TRP GLY ARG ILE VAL THR LEU ILE SER PHE GLY SEQRES 37 A 518 ALA PHE VAL ALA LYS HIS LEU LYS THR ILE ASN GLN GLU SEQRES 38 A 518 SER CYS ILE GLU PRO LEU ALA GLU SER ILE THR ASP VAL SEQRES 39 A 518 LEU VAL ARG THR LYS ARG ASP TRP LEU VAL LYS GLN ARG SEQRES 40 A 518 GLY TRP ASP GLY PHE VAL GLU PHE PHE HIS VAL HET GLC B 1 12 HET GLC B 2 11 HET 70R A 401 57 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM 70R (2~{R})-2-[5-[3-CHLORANYL-2-METHYL-4-[2-(4- HETNAM 2 70R METHYLPIPERAZIN-1-YL)ETHOXY]PHENYL]-6-(5- HETNAM 3 70R FLUORANYLFURAN-2-YL)THIENO[2,3-D]PYRIMIDIN-4-YL]OXY-3- HETNAM 4 70R [2-[[2-[2,2,2-TRIS(FLUORANYL)ETHYL]PYRAZOL-3- HETNAM 5 70R YL]METHOXY]PHENYL]PROPANOIC ACID HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC 2(C6 H12 O6) FORMUL 3 70R C39 H37 CL F4 N6 O6 S FORMUL 4 HOH *183(H2 O) HELIX 1 AA1 GLY A -180 GLY A -164 1 17 HELIX 2 AA2 LYS A -154 ALA A -144 1 11 HELIX 3 AA3 ARG A -130 SER A -123 1 8 HELIX 4 AA4 ASP A -114 ASP A -109 1 6 HELIX 5 AA5 TYR A -106 VAL A -99 1 8 HELIX 6 AA6 GLU A -65 ALA A -55 1 11 HELIX 7 AA7 GLU A -43 ASP A -32 1 12 HELIX 8 AA8 ASN A -11 ASN A 5 1 17 HELIX 9 AA9 ASP A 13 LYS A 23 1 11 HELIX 10 AB1 GLY A 32 TRP A 34 5 3 HELIX 11 AB2 ALA A 35 SER A 42 1 8 HELIX 12 AB3 ASN A 76 TYR A 87 1 12 HELIX 13 AB4 THR A 90 LYS A 101 1 12 HELIX 14 AB5 LEU A 108 ALA A 116 1 9 HELIX 15 AB6 ASP A 118 GLY A 131 1 14 HELIX 16 AB7 GLN A 139 SER A 156 1 18 HELIX 17 AB8 THR A 160 GLY A 192 1 33 HELIX 18 AB9 SER A 202 HIS A 224 1 23 HELIX 19 AC1 HIS A 224 LEU A 235 1 12 HELIX 20 AC2 ASN A 239 ASP A 256 1 18 HELIX 21 AC3 ASN A 260 ILE A 281 1 22 HELIX 22 AC4 GLN A 283 SER A 285 5 3 HELIX 23 AC5 CYS A 286 LYS A 302 1 17 HELIX 24 AC6 LYS A 302 GLN A 309 1 8 HELIX 25 AC7 ARG A 310 PHE A 319 1 10 SHEET 1 AA1 6 LYS A-162 GLU A-158 0 SHEET 2 AA1 6 LYS A-190 TRP A-186 1 N ILE A-187 O THR A-160 SHEET 3 AA1 6 ILE A-137 ALA A-133 1 O ILE A-137 N TRP A-186 SHEET 4 AA1 6 PHE A 62 ILE A 70 -1 O GLY A 69 N ILE A-136 SHEET 5 AA1 6 TYR A -90 GLU A -85 -1 N ILE A -88 O LEU A 66 SHEET 6 AA1 6 ALA A 105 VAL A 106 -1 O ALA A 105 N VAL A -86 SHEET 1 AA2 5 LYS A-162 GLU A-158 0 SHEET 2 AA2 5 LYS A-190 TRP A-186 1 N ILE A-187 O THR A-160 SHEET 3 AA2 5 ILE A-137 ALA A-133 1 O ILE A-137 N TRP A-186 SHEET 4 AA2 5 PHE A 62 ILE A 70 -1 O GLY A 69 N ILE A-136 SHEET 5 AA2 5 GLU A 132 ILE A 133 1 O GLU A 132 N VAL A 63 SHEET 1 AA3 2 ARG A -98 TYR A -97 0 SHEET 2 AA3 2 LYS A -94 LEU A -93 -1 O LYS A -94 N TYR A -97 SHEET 1 AA4 3 MET A 28 ASN A 31 0 SHEET 2 AA4 3 SER A -82 ASN A -78 -1 N ILE A -80 O THR A 29 SHEET 3 AA4 3 TYR A 46 THR A 49 -1 O THR A 49 N LEU A -81 SHEET 1 AA5 2 TYR A -29 LYS A -26 0 SHEET 2 AA5 2 ASP A -19 GLY A -14 -1 O ASP A -19 N LYS A -26 LINK O4 GLC B 1 C1 GLC B 2 1555 1555 1.44 CRYST1 99.400 136.760 38.330 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010060 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007312 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026089 0.00000